TekATL
Posted - 1 week ago
$CBUS handle here sets up for 9/10 area
xbizo
Posted - 1 week ago
$CBUS Runs out of cash next quarter. Becareful!
debbiekatz
Posted - 2 weeks ago
very nice patient swing on $cbus now at 5.08. posted as a buy and hold for team on 10/10 at 3.16. made 61% gain so far.
Ava_Parker
Posted - 2 weeks ago
$MASS $CBUS MYNZ +10.91% PM LFG, unusually high volume activity last week, apx 30% more than average. 👇😘🚀 This stock may see the last time this price per share PT $5+ 🚀 HUGE PRs drop incoming before the Nov 13 meeting, so compliance is coming—no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead.
StockScanners
Posted - 1 month ago
$CBUS Waiting for this to cook
StockScanners
Posted - 1 month ago
$CBUS Keep watch if this holds above 3.75
debbiekatz
Posted - 1 month ago
$CBUS at 3.7 - nice swing for team getting in at 3.15 on 10/10. will need to get thru resistance here to move towards 5
Waldairz
Posted - 1 month ago
$CBUS Rory prob just made the $250K purchase. Probably sold the company copiers to make the purchase lol
Waldairz
Posted - 1 month ago
$CBUS the company will be OUT OF Money in 3 months. They will either go bankrupt or dilute. Either at shares will tank. Save your money and look elsewhere in the market!
Waldairz
Posted - 1 month ago
$CBUS junk. I don’t know who would be buying this. It is down nearly 90% since merger. They have no product or technology. Company was build on lies.
Waldairz
Posted - 1 month ago
$CBUS a $75M Company valuation now. Looks like Bonitas Research was right! Massive Fraud here on the backs of Mom & Pop investors that represents everything that is wrong with the market.
mtrotb
Posted - 1 month ago
$CBUS Just sold this POS stock I bought 3 years ago. I invested around $2200. Just sold for $3.08.
TheLearnerEarner
Posted - 1 month ago
$CBUS ✅ HUGELY UNDERVALUED QUALITY stock swing trade - healthcare - microcap - 4/9 F-Score - 0.77x relative volume - revenue is forecast to grow 62.11% per year - short to medium term gains 📈 RSI: 30.97 (oversold bullish) 📊🐂 Analyst Price Target: $22.83 - $26.25 (643.65% - 755.05% above Price) 🌟 Range (12m) $2.98 - $23.18 💰 NEWSDESK (last recent article) 📰 https://finance.yahoo.com/news/cibus-participate-food-forum-during-170100351.html
xbizo
Posted - 1 month ago
@Waldairz Would like u to explain Rory 'lying and stealing' from $CBUS . That's libel if there are no facts to back it up
Waldairz
Posted - 1 month ago
$CBUS what do you think the people that bought the secondary at $10 are thinking now? What about the people that lost 20% in the past week who bought in at $4? Additional liquidity is going to be nearly impossible to obtain without wiping out shareholders. Employees will be notified shortly of job reductions. Rory been Lying and Stealing.
Waldairz
Posted - 1 month ago
$CBUS soon $2 or less. Reverse split, and absolutely ridiculous dilution. Rory be lying and stealing. Gotta be crazy to invest money in this POS.
xbizo
Posted - 1 month ago
@PennyHawker I think $CBUS is wait and see stock. Runway to profit is still long. Management isn't trustworthy. Also, insiders are putting themselves in front of common shareholders. $23 is an old target. Doubt u see that in 6-12 months. Maybe it's $5. Maybe it's $2.
Waldairz
Posted - 1 month ago
$CBUS “this is the biggest thing I will have ever done” can be translated to “this is the biggest fraud I will have ever commmited”
Waldairz
Posted - 1 month ago
$CBUS down 90% since merger. No reason to buy this.
Waldairz
Posted - 09/30/24
$CBUS getting closer to my < &2 target. Company is a complete fraud. Please read just about any recent press release which contain many qualifying words that take specificity out of the press release, and thus provide a defense against and potential litigation.
Waldairz
Posted - 09/27/24
$CBUS reverse split by 11/30/24. 1:10 9r 1:20 likely if they can get investors or buyer. It that does not work out they will file for bankruptcy protection.
Waldairz
Posted - 09/26/24
$CBUS shareholders will be wiped out by January. Rory has egregiously overhyped the technology and should end up behind bars.
Coley35
Posted - 09/26/24
$CBUS Sink to $2 at least. Hopeless investment.
NateInvest
Posted - 09/26/24
$CBUS: Sounds like Cibus is makin' moves! 🤔 That partnership could def be a game changer if they execute well. Keep an eye on this one—could be primed for a breakout. 📈 $JAMF: Solid earnings beat! 13.3% rev growth is no joke. Looks like Apple’s still driving strong demand for them. 🚀 Bullish on their future if they keep delivering. $MYNZ: FDA Breakthrough Device app? 🩺 That’s HUGE! If they get it, fast track approval could open up some serious opportunities. Definitely worth a closer look for long-term gains. 💪 What do y'all think? Got any of these on your radar?👀
ManosDeDiamante07
Posted - 09/23/24
$CBUS Adding here with a tight stop loss at 3.49
Waldairz
Posted - 09/23/24
$CBUS probably will not get many fake “good news” stories for awhile. Management will not want to get in trouble for pumping their stock given the company faces imminent threat of bankruptcy. However, the more likely scenario the that the company will be acquired, albeit for just a few cents. Shares will be under 2 shortly.
ManosDeDiamante07
Posted - 09/22/24
$CBUS $6.50s coming soon
xbizo
Posted - 2 months ago
$CBUS and remember, there's this little royalty agreement with early founders where get 10% of REVENUE for the next 50 years or so.... How do you make decent EBITDA with that cost?
xbizo
Posted - 2 months ago
$CBUS SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the pricing of an underwritten public offering of 3,000,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) at a public offering price of $4.00 per share. The Company has granted the underwriters a 45-day option to purchase an additional 450,000 shares of Class A Common Stock to cover over-allotments, if any. All shares of Class A Common Stock to be sold in the offering are to be sold by the Company.